Skip to main content
. 2021 Mar 24;296:100588. doi: 10.1016/j.jbc.2021.100588

Figure 6.

Figure 6

Quantification of intracellular pSTAT5 concentrations in SK-MEL-28 cells by ELISA following co-treatment with human growth hormone (hGH) and various inhibitors. Intracellular pSTAT5 levels are plotted as fold-induction compared with untreated controls. All peptide variants were treated at 200 nM. Pegvisomant (Peg.) was treated at 100 nM. Statistical significance indicates level of inhibition compared to cells treated with hGH alone. ∗p < 0.05, ∗∗p < 0.01, ∗∗∗p < 0.005.